Revvity Inc.

Revvity Inc.

RVTY

Get informed when a big investor buys or sells

+ Follow
Market Cap$16.9B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Revvity Inc.Revvity Inc.72.20.18%3%5.80.5
$136.00

Target Price by Analysts

10.2% downsideRevvity Target Price DetailsTarget Price
$58.70

Current Fair Value

61.3% downside

Overvalued by 61.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$16.90 Billion
Enterprise Value$19.22 Billion
Dividend Yield$0.28 (0.18%)
Earnings per Share$2.08
Beta1.09
Outstanding Shares111,746,000

Return

Return on Equity3.29%ROE
Return on Assets1.97%
Return on Invested Capital3.31%

Valuation & Multiples

P/E Ratio72.16P/E Ratio
PEG-1829.29PEG
Price to Sales5.83Price to Sales
Price to Book Ratio2.37Price to Book Ratio
Enterprise Value to Revenue6.6
Enterprise Value to EBIT54.01
Enterprise Value to Net Income80
Total Debt to Enterprise0.17
Debt to Equity0.46Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$1.21
Average shareholder expectation
Revenue Estimate
$702.96 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 26, 2026
EPS Estimate
$1.29
Average shareholder expectation
Revenue Estimate
$694.23 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.4904▼ 1150.33%
Total Calls78,500▲ 23.10%
Total Puts38,500▼ 94.97%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %102.96%▼ 0.27%
Total Invested$12.80B▲ 26.56%
Investors Holding554▲ 42.00%

ESG Score

No data

About Revvity Inc.

16,700 employees
CEO: Prahlad Singh

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to ser...